Myriad Genetics MYGN Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's total liabilities & equity?
- Myriad Genetics (MYGN) reported total liabilities & equity of $673.7M in Q1 2026.
- How has Myriad Genetics's total liabilities & equity changed year-over-year?
- Myriad Genetics's total liabilities & equity decreased by 33.0% year-over-year, from $1.01B to $673.7M.
- What is the long-term trend for Myriad Genetics's total liabilities & equity?
- Over 5 years (2020 to 2025), Myriad Genetics's total liabilities & equity has grown at a -13.0% compound annual growth rate (CAGR), from $1.42B to $706.6M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.